All Stories

  1. Genome-wide association meta-analysis highlights light-induced signaling as a driver for refractive error
  2. Diagnostic Performance and Repeatability of a Novel Game-Based Visual Field Test for Children
  3. Reply
  4. Optimizing OCT acquisition parameters for assessments of vitreous haze for application in uveitis
  5. The effect of haemopoietic stem cell transplantation on the ocular phenotype in mucopolysaccharidosis type I (Hurler)
  6. Generative mathematical modelling to demonstrate virtual simulations of neovascular age related macular degeneration
  7. Swept-Source Optical Coherence Tomography Angiography Findings in Torpedo Maculopathy
  8. Vitamin D and Age-Related Macular Degeneration
  9. Use of a Neural Net to Model the Impact of Optical Coherence Tomography Abnormalities on Vision in Age-related Macular Degeneration
  10. QUANTITATIVE ANALYSIS OF PIGMENT EPITHELIAL DETACHMENT RESPONSE TO DIFFERENT ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN WET AGE-RELATED MACULAR DEGENERATION
  11. Fingolimod-associated macular oedema
  12. Experience of Anti-VEGF Treatment and Clinical Levels of Depression and Anxiety in Patients With Wet Age-Related Macular Degeneration
  13. Objective Quantification of Changes in Corneal Clouding Over Time in Patients With Mucopolysaccharidosis
  14. Feasibility of Use of a Mobile Application for Nutrition Assessment Pertinent to Age-Related Macular Degeneration (MANAGER2)
  15. Development of a Pediatric Visual Field Test
  16. Feasibility Study of Interactive Game Technologies to Improve Experience with Inhaler Spacer Devices in Young Children
  17. Normal Threshold Size of Stimuli in Children Using a Game-Based Visual Field Test
  18. Automated Measurement of Visual Acuity in Pediatric Ophthalmic Patients Using Principles of Game Design and Tablet Computers
  19. Patient Perceptions and Experiences of Stereotactic Radiotherapy for Wet Age-Related Macular Degeneration
  20. Use of new imaging in detecting and monitoring ocular manifestations of the mucopolysaccharidoses
  21. Psychological impact of anti-VEGF treatments for wet macular degeneration—a review
  22. Associations with Intraocular Pressure in a Large Cohort
  23. Spectral-Domain Optical Coherence Tomography Imaging in 67 321 Adults
  24. Development and testing of an automated computer tablet-based method for self-testing of high and low contrast near visual acuity in ophthalmic patients
  25. The Evolution of Teleophthalmology Programs in the United Kingdom
  26. Evaluation of Objective Vitritis Grading Method Using Optical Coherence Tomography: Influence of Phakic Status and Previous Vitrectomy
  27. The Novel Evidenced Assessment of Tortuosity system: interobserver reliability and agreement with clinical assessment
  28. Role of Educational Exposure in the Association Between Myopia and Birth Order
  29. Omega-3 Fatty Acids and Age-Related Macular Degeneration
  30. Frequency and Distribution of Refractive Error in Adult Life: Methodology and Findings of the UK Biobank Study
  31. Automated Analysis of Vitreous Inflammation Using Spectral-Domain Optical Coherence Tomography
  32. Measures of socioeconomic status and self-reported glaucoma in the UK Biobank cohort
  33. New superior–inferior visual field asymmetry indices for detecting POAG and their agreement with the glaucoma hemifield test
  34. High Tech Aids Low Vision: A Review of Image Processing for the Visually Impaired
  35. Routine versus As-Needed Bevacizumab with 12-Weekly Assessment Intervals for Neovascular Age-Related Macular Degeneration
  36. Dexamethasone Intravitreal Implant as Adjunctive Therapy to Ranibizumab in Neovascular Age-Related Macular Degeneration: A Multicenter Randomized Controlled Trial
  37. Suitability of UK Biobank Retinal Images for Automatic Analysis of Morphometric Properties of the Vasculature
  38. STEREOTACTIC RADIOTHERAPY FOR WET AGE-RELATED MACULAR DEGENERATION (INTREPID)
  39. Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration
  40. European survey on the opinion and use of micronutrition in age-related macular degeneration: 10 years on from the Age-Related Eye Disease Study
  41. A novel technique for measuring dark adaptation using a dual stimulus method: Effects of aging and AMD on dark adaptation
  42. Optimisation and Assessment of Three Modern Touch Screen Tablet Computers for Clinical Vision Testing
  43. Comparison of mathematical morphological descriptors of hyporeflective cavities in optical coherence tomography of patients with macular telangiectasia compared to patients with diabetic maculopathy
  44. The association between dark adaptation and macular pigment optical density in healthy subjects
  45. Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
  46. Stereotactic Radiotherapy for Neovascular Age-related Macular Degeneration
  47. Repeatability of visual function measures in age-related macular degeneration
  48. An assessment of a modern touch-screen tablet computer with reference to core physical characteristics necessary for clinical vision testing
  49. Assessment of age changes and repeatability for computer-based rod dark adaptation
  50. Micronutrients in Age-Related Macular Degeneration
  51. Differences in spectral absorption properties between active neovascular macular degeneration and mild age related maculopathy
  52. Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
  53. Use of iris recognition camera technology for the quantification of corneal opacification in mucopolysaccharidoses
  54. Short-term changes of visual hallucinations after intravitreal injection of ranibizumab in age related macular degeneration
  55. Contrast Sensitivity Outcomes in the ABC Trial: A Randomized Trial of Bevacizumab for Neovascular Age-Related Macular Degeneration
  56. A novel paediatric game-based visual-fields assessor
  57. Development of inositol-based antagonists for thed-myo-inositol 1,4,5-trisphosphate receptor
  58. Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics
  59. Short-term changes of visual hallucinations after intravitreal injection of ranibizumab in neovascular age-related macular degeneration
  60. Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study
  61. Analysis of posterior capsule opacification
  62. Evaluating Patient Discomfort, Anxiety, and Fear Before and After Ranibizumab Intravitreous Injection for Wet Age-Related Macular Degeneration
  63. Digital image analysis of plus disease in retinopathy of prematurity
  64. Iris recognition in the presence of ocular disease
  65. A system for computerised retinal haemorrhage analysis
  66. Contextual detection of ischemic regions in ultra-wide-field-of-view retinal fluorescein angiograms
  67. Synthesis and Biological Action of Novel 4-Position-Modified Derivatives ofd-myo-Inositol 1,4,5-Trisphosphate
  68. The Association between Retinal Vascular Network Geometry and Cognitive Ability in an Elderly Population
  69. Long-term Prevalence of Pseudophakic Photic Phenomena
  70. Principles of disability glare measurement: an ophthalmological perspective
  71. OSCA: a comprehensive open-access system of analysis of posterior capsular opacification
  72. Asymmetry of Retinal Arteriolar Branch Widths at Junctions Affects Ability of Formulae to Predict Trunk Arteriolar Widths
  73. Reply
  74. Measurement of photic phenomena
  75. Retinal image analysis: Concepts, applications and potential
  76. Statistical strategies to assess reliability in ophthalmology
  77. Effect of Axial Length on Retinal Vascular Network Geometry
  78. Sub-Tenon???s Anesthetic Administration for Cataract Surgery: How Much Stays In?
  79. Assessment of systems of analyzing PCO
  80. A freely accessible, evidence based, objective system of analysis of posterior capsular opacification ; Evidence for its validity and reliability
  81. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures
  82. Measurement Validity in Ophthalmology
  83. Development of a Forced Choice Photographic Questionnaire for Photic Phenomena and Its Testing – Repeatability, Reliability and Validity
  84. Effect of volume used in sub-Tenon's anaesthesia on efficacy and intraocular pressure: a randomized clinical trial of 3 mL versus 5 mL
  85. Methods of assessment of patients for Nd:YAG laser capsulotomy that correlate with final visual improvement
  86. Statistical analysis of agreement in measurement comparison studies
  87. Does a small central Nd:YAG posterior capsulotomy improve peripheral fundal visualisation for the Vitreoretinal surgeon?
  88. COMPLETE OCCLUSION OF THE ANTERIOR CAPSULAR OPENING BY FIBROCELLULAR MEMBRANE ASSOICATED WITH RETAINED SILICONE OIL
  89. Correlation between posterior capsule opacification and visual function before and after neodymium:YAG laser posterior capsulotomy
  90. Author's response to Schubert
  91. Letters to the Editor
  92. Videokeratoscopic indices for keratitis sicca
  93. The development and assessment of a self-perceived quality of vision questionnaire to test pseudophakic patients
  94. Pseudophakic retinal detachment after Nd:YAG capsulotomy
  95. Principles of Pseudophakic Photic Phenomena
  96. Use of Nd:YAG laser capsulotomy
  97. Chorioretinal Anastomosis Probably Occurs Infrequently in Type 2A Idiopathic Juxtafoveolar Retinal Telangiectasis
  98. Reproducibility and clinical application of a newly developed stabilized retinal laser Doppler instrument
  99. Posterior capsule morphology determinants of visual function
  100. Neodymium:YAG laser capsulotomy: a clinical morphological analysis
  101. Systems of analysis of posterior capsule opacification
  102. Digital Imaging to Characterize Retinal Vascular Topography